Lilly Asia Ventures

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Lilly Asia Ventures — overview

About

Lilly Asia Ventures (LAV) is a China-based venture capital firm that employs a long-term growth strategy. The firm invests globally in companies ranging from the seed stage to the publicly traded stage across the biopharmaceuticals, human therapeutics, medical devices, and diagnostics sectors. It has offices in Hong Kong and Palo Alto. LAV became an independent investment management company following its spin-off in 2011.

Lilly Asia Ventures - known decision makers (14)

Position	Location	Asset Class
Chief Finance Officer, USD Funds	Central, Hong Kong	PE
Chief Investment Officer	Shanghai, China	PEPENRNR
Managing Director	Shanghai, China	PE
Managing Director & Founder	Menlo Park, US	PEPENRNR
Managing Partner	Shanghai, China	PEPENRNR

Showing 5 of 14 known decision makers Lilly Asia Ventures

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo